Abdul is a Pharmacist by education and received his PhD in Pharmaceutics in 1999. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He is an international authority on oral drug delivery and absorption, and has published over 300 papers, book chapters, abstracts and patents. He leads a large and multi-disciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies (incl. COLAL™, PHLORAL™, ProRelease™ and DuoCoat™) and improved disease treatments, many of which are currently in late stage clinical trials. Abdul is the recipient of the 2004 Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS), and is the only non-North American scientist to receive this award. He is also the recipient of the 2014 Academy of Pharmaceutical Sciences (APS) award. He is a frequent speaker at international conferences, serves as a consultant to numerous pharmaceutical companies and sits on the advisory boards of healthcare organisations and charitable bodies.